Literature DB >> 30654994

Illness perceptions of stroke survivors: Predictors and changes over time - A 1 year follow-up study.

I F Groeneveld1, S L van der Pas2, J J L Meesters3, J M Schuurman4, W van Meijeren-Pont5, E Jagersma4, P H Goossens5, A A Kaptein6, T P M Vliet Vlieland5.   

Abstract

OBJECTIVE: To describe the illness perceptions (IP) of stroke patients in the first year post stroke; to identify patient clusters with comparable IP trajectories and determine their associations with health.
METHODS: This prospective study included consecutive stroke patients after medical rehabilitation. Three and 12 months post stroke they completed the Brief Illness Perception Questionnaire (B-IPQ) and questionnaires on physical and mental health. All eight IP and their changes over time were described. Clusters of patients with comparable IP trajectories were constructed by k-means clustering, with subsequent comparison of patient characteristics. Multivariable logistic regression analyses were conducted to determine the association between IP clusters and 12-month mental health.
RESULTS: Hundred-and-eighty-four patients were included (men n = 107 [58.2%]; mean age 61.1 [SD 12.7] years). At 3 months, the scores of the IP coherence (mean 3.0, SD 2.3) and treatment control (mean 3.2, SD 2.5) were lowest (best), and consequences (mean 6.1, SD 2.8) and anticipated timeline (mean 6.0, SD 2.7) were highest (worst). At 12 months, the timeline and treatment control scores had significantly worsened. Three clusters of the trajectories of IP were identified, and designated as 'favourable', 'average', and 'unfavourable'. The unfavourable cluster was significantly associated with worse physical and mental health at 3 months (unadjusted) and depressive symptoms at 12 months.
CONCLUSION: Stroke patients' IP partly changed between 3 and 12 months post stroke. Patients with an unfavourable IP trajectory had a higher chance of depressive symptoms at 12 months. Illness perceptions could be considered as an additional target of treatment.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  “Depressive symptoms”; “Health outcomes”; “Illness perceptions”; “Longitudinal study”; “Rehabilitation”; “Stroke”

Mesh:

Year:  2018        PMID: 30654994     DOI: 10.1016/j.jpsychores.2018.10.019

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  5 in total

1.  Illness perceptions and health-related quality of life in individuals with overweight and obesity.

Authors:  Fathimah S Sigit; Renée de Mutsert; Hildo J Lamb; Yvette Meuleman; Adrian A Kaptein
Journal:  Int J Obes (Lond)       Date:  2021-11-06       Impact factor: 5.095

2.  Heart in art: cardiovascular diseases in novels, films, and paintings.

Authors:  Ad A Kaptein; Pim B van der Meer; Barend W Florijn; Alexander D Hilt; Michael Murray; Martin J Schalij
Journal:  Philos Ethics Humanit Med       Date:  2020-02-13       Impact factor: 2.464

3.  Commentary on: Effect of a comprehensive E-rehabilitation Intervention alongside conventional stroke rehabilitation on disability and Health-Related quality of life: A Pre-Post comparison.

Authors:  Kanika X; Gurjant Singh
Journal:  J Rehabil Med       Date:  2021-07-15       Impact factor: 2.912

4.  Age, Cognitive Factors, and Acceptance of Living with the Disease in Rheumatoid Arthritis: The Short-Term Perspective.

Authors:  Daniel Pankowski; Kinga Wytrychiewicz-Pankowska; Ewa Pisula; Andrzej Fal; Bartłomiej Kisiel; Ewa Kamińska; Witold Tłustochowicz
Journal:  Int J Environ Res Public Health       Date:  2022-03-07       Impact factor: 3.390

5.  Effect of a comprehensive eRehabilitation intervention alongside conventional stroke rehabilitation on disability and health-related quality of life: A pre-post comparison.

Authors:  Berber Brouns; Leti van Bodegom-Vos; Arend J de Kloet; Sietske J Tamminga; Gerard Volker; Monique A M Berger; Marta Fiocco; Paulien H Goossens; Thea P M Vliet Vlieland; Jorit J L Meesters
Journal:  J Rehabil Med       Date:  2021-03-05       Impact factor: 2.912

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.